Parmax Pharma Ltd — Important, 01-01-1970: Company Update

Parmax Pharma Limited's Committee of Independent Directors has published its assessment regarding the open offer. Acquirers Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with persons acting in concert, seek to acquire 23.46 lakh equity shares of ₹10 face value, representing 26.00% of the company's expanded voting share capital. This assessment offers public shareholders crucial insights into the offer, aiding their investment decisions concerning Parmax Pharma.